ArticleAnnals of translational medicine2019

Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer.

Rossana Berardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.